Trial Profile
The efficacy and safety of tocilizumab (trade name: Actemra) in RA patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2010
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 10 Jan 2010 New trial record